| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
General Counsel &Corp Sec | General Counsel &Corp Sec
1 company
Allan Jonathan is a General Counsel &Corp Sec at Stoke Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $477K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | STOK Stoke Therapeutics, Inc. | General Counsel &Corp Sec | Sale+OE | 8,599 | $15.04 | $129,327.24 | -76.8% | -7.8% | -37.6% | |
| Mar 28, 2024 | STOK Stoke Therapeutics, Inc. | General Counsel &Corp Sec | Sell | 5,126 | $13.20 | $67,667.91 | -49.2% | -4.3% | -46.6% | |
| Mar 19, 2024 | STOK Stoke Therapeutics, Inc. | General Counsel &Corp Sec | Sale+OE | 2,349 | $6.10 | $14,325.61 | -23.3% | +169.0% | +42.4% | |
| Jun 21, 2023 | STOK Stoke Therapeutics, Inc. | General Counsel &Corp Sec | Sell | 1,948 | $13.48 | $26,252.22 | -100% | -64.7% | +9.3% |